Device to create human platelets could transform transfusion

The successful creation of human platelets by researchers in vitro could transform the blood transfusion market. A platelet bioreactor was developed by researchers at Brigham and Women's Hospital. The device is modeled after bone marrow and can be used to treat chemotherapy and organ transplant patients, in surgeries and for emergency trauma use. The researchers expect to begin clinical testing in 2017. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.